Health

Long-Term Care After COVID-19

Long-Term Care After COVID-19

Experts recommend regulatory policies to improve long-term care in the wake of COVID-19.

State Failures to Survey Nursing Homes

State Failures to Survey Nursing Homes

A report recommends ways CMS can address the states’ failures to meet nursing home survey requirements.

Preparing the New Market for Meat Alternatives

Preparing the New Market for Meat Alternatives

As the alternative meat industry takes off, regulation will confront a new frontier.

Immigration Surveillance in Health Care

Immigration Surveillance in Health Care

Scholar calls for increased protections for noncitizens within the health care system.

Protecting Abortion Post-Roe

Protecting Abortion Post-Roe

Scholars offer suggestions for protecting abortion rights if the Supreme Court overturns Roe v. Wade.

Who is Your Health Insurer?

Who is Your Health Insurer?

More employers self-fund health insurance plans, bypassing state regulation and potentially increasing costs.

Sniffing Out New Regulation

Sniffing Out New Regulation

Scholars propose to modify the current regulatory regime for animal-based medical diagnostics.

Last Federal Mask Mandate Standing

Last Federal Mask Mandate Standing

A federal judge rules CDC cannot require travelers to wear masks on airplanes or public transportation.

Help International Medical Graduates Help Us

Help International Medical Graduates Help Us

In the United States, immigration and administrative barriers hinder a valuable supply of health care workers.

Hidden Racial Disparities in FDA-Required Research

Hidden Racial Disparities in FDA-Required Research

Current testing practices in the pharmaceutical industry exploit social and racial inequities.

The (Un)Regulation of Tattoo Ink

The (Un)Regulation of Tattoo Ink

FDA should increase its regulatory oversight of tattoo ink safety.

CMS Confronts an Increase in Medicare Part B Premiums

CMS Confronts an Increase in Medicare Part B Premiums

CMS reconsiders a recent Medicare premium increase after restricting coverage for a controversial new drug.